Silence Therapeutics plc (SLN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2022: -$57.04M2023: -$49.46M2024: -$67.64M2025: -$62.27M-$62.27M
2022Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$62.27M+7.9%
2024-$67.64M-36.8%
2023-$49.46M+13.3%
2022-$57.04M